The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-(2-cyclopropyl-5-(1-methyl-1H-pyrazol-4-ylamino)phenylamino)propyl)cyclobutanecarboxamide ID: ALA4573298
PubChem CID: 155563115
Max Phase: Preclinical
Molecular Formula: C21H29N5O
Molecular Weight: 367.50
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cc(Nc2ccc(C3CC3)c(NCCCNC(=O)C3CCC3)c2)cn1
Standard InChI: InChI=1S/C21H29N5O/c1-26-14-18(13-24-26)25-17-8-9-19(15-6-7-15)20(12-17)22-10-3-11-23-21(27)16-4-2-5-16/h8-9,12-16,22,25H,2-7,10-11H2,1H3,(H,23,27)
Standard InChI Key: MEGXTIMYQWZJNA-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
9.6192 -6.9296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6180 -7.7491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3261 -8.1581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0357 -7.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0329 -6.9260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3243 -6.5207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3304 -8.9733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9216 -9.6809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7388 -9.6811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7441 -8.1561 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4511 -7.7464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1595 -8.1539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8665 -7.7442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5749 -8.1517 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2820 -7.7420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9903 -8.1495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2807 -6.9248 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.2008 -8.9364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9898 -8.7237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7771 -7.9346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3218 -5.7035 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0283 -5.2928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7744 -5.6252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3194 -5.0163 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9086 -4.3098 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1099 -4.4822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1328 -5.0146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
8 7 1 0
9 8 1 0
7 9 1 0
3 7 1 0
4 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
15 17 2 0
16 18 1 0
18 19 1 0
19 20 1 0
20 16 1 0
6 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 1 0
25 26 2 0
26 22 1 0
24 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 367.50Molecular Weight (Monoisotopic): 367.2372AlogP: 3.76#Rotatable Bonds: 9Polar Surface Area: 70.98Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.70CX LogP: 2.40CX LogD: 2.40Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.59Np Likeness Score: -1.67
References 1. Sintim HO, Mikek CG, Wang M, Sooreshjani MA.. (2019) Interrupting cyclic dinucleotide-cGAS-STING axis with small molecules., 10 (12): [PMID:32206239 ] [10.1039/C8MD00555A ]